DVAX Insider Trading

Insider Ownership Percentage: 2.98%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $43,126.95

Dynavax Technologies Insider Trading History Chart

This chart shows the insider buying and selling history at Dynavax Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal Insider BuyingTotal Insider Selling

Dynavax Technologies Share Price & Price History

Current Price: $12.71
Price Change: Price Decrease of -0.26 (-2.00%)
As of 04/1/2025 05:00 PM ET

This chart shows the closing price history over time for DVAX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$12.97Closing price on 03/31/25:

SEC Filings (Institutional Ownership Changes) for Dynavax Technologies (NASDAQ:DVAX)

96.96% of Dynavax Technologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at DVAX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$193Mbought$109MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$100M$0$100MTotal InflowsTotal Outflows
Dynavax Technologies logo
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.
Read More on Dynavax Technologies

Today's Range

Now: $12.71
Low: $12.63
High: $12.97

50 Day Range

MA: $13.36
Low: $12.42
High: $14.40

52 Week Range

Now: $12.71
Low: $9.74
High: $14.63

Volume

1,822,119 shs

Average Volume

2,138,333 shs

Market Capitalization

$1.58 billion

P/E Ratio

70.61

Dividend Yield

N/A

Beta

1.23

Who are the company insiders with the largest holdings of Dynavax Technologies?

Dynavax Technologies' top insider shareholders include:
  1. Andrew A F Hack (Director)
  2. Robert Janssen (CMO)
  3. Francis Cano (Director)
  4. David F Novack (COO)
  5. Justin Burgess (CAO)
Learn More about top insider investors at Dynavax Technologies.